Search

The production of transuranium isotopes has been demonstrated at the Isotope Separation and ACceleration (ISAC) facility. In particular a laser-ionized $^{239}$Pu beam, extracted from a uranium carbide target, was investigated. The experimental work was complemented by GEANT4 simulations, modelling the impact of secondary particles on the creation of transuranium isotopes through inelastic nuclear reactions. Theoretical production cross sections were derived and compared to experimental results, leading to a discussion on boundary conditions for the release of neptunium and plutonium from ISAC uranium carbide targets.

States compete in seeking to host international institutions. To this end Germany recently adopted a national host state act offering interested institutions and their organizational units an extensive catalogue of privileges and immunities. This piece presents the act and addresses the question of its applicability to organizations and any subsidiaries hosted under earlier international instruments.

The Advanced Rare IsotopE Laboratory (ARIEL) will increase TRIUMF’s radioactive ion beam capabilities. As part of the ARIEL target material research and development campaign, a new method to produce targets of mixed uranium carbide with excess graphite has been proposed and tested. The resulting material is comparable in composition with the conventional target material and is produced ten times faster. The reduction in production time will liberate the resources and equipment for research and development leading to new target materials with improved radioisotope release properties for ARIEL.

Determination of the constituents of the radioactive ion beam (RIB) is crucial for successful experiments at low-energy RIB facilities and as such decides the fate of many experiments. Here we present the role of TITAN’s Multiple-Reflection Time-Of-Flight Mass Separator (MR-TOF-MS) and how it complements the present capabilities at ISAC-TRIUMF for yield determinations and beam delivery. This non-scanning, broadband, high-resolution mass spectrometer allows for real-time identification and quantification of all species, ranging from radionuclides with half-lives as low as a few ms to stable isotopes and molecules. In this manner it can be efficiently used to optimize RIB delivery through the ISAC mass separator for rate of the species of interest or its ratio to contamination. We present an example of this optimization approach, where the purity of secondary beams of neutron-rich titanium was improved by more than one order of magnitude based on the diagnostics capabilities of the new MR-TOF-MS and thus, allowed for high-precision mass measurements at TITAN.

Objective. The development of alpha-emitting radiopharmaceuticals using 225Ac (t ½ = 9.92 d) benefits from the quantitative determination of its biodistribution and is not always easy to directly measure. An element-equivalent matched-pair would allow for more accurate biodistribution and dosimetry estimates. 226Ac (t ½ = 29.4 h) is a candidate isotope for in vivo imaging of preclinical 225Ac radiopharmaceuticals, given its 158 keV and 230 keV gamma emissions making it suitable for quantitative SPECT imaging. This work aimed to conduct a performance assessment for 226Ac imaging and presents the first-ever 226Ac SPECT images. Approach. To establish imaging performance with regards to contrast and noise, image quality phantoms were scanned using a microSPECT/CT system. To assess the resolution, a hot rod phantom with cylindrical rods with diameters between 0.85 and 1.70 mm was additionally imaged. Two collimators were evaluated: a high-energy ultra-high resolution (HEUHR) collimator and an extra ultra-high sensitivity (UHS) collimator. Images were reconstructed from two distinct photopeaks at 158 keV and 230 keV. Main results. The HEUHR SPECT image measurements of high activity concentration regions were consistent with values determined independently via gamma spectroscopy, within 9% error. The lower energy 158 keV photopeak images demonstrated slightly better contrast recovery. In the resolution phantom, the UHS collimator only resolved rods ≥1.30 mm and ≥1.50 mm for the 158 keV and 230 keV photopeaks, respectively, while the HEUHR collimator clearly resolved all rods, with resolution Significance. Overall, the feasibility of preclinical imaging with 226Ac was demonstrated with quantitative SPECT imaging achieved for both its 158 keV and 230 keV photopeaks. The HEUHR collimator is recommended for imaging 226Ac activity distributions in small animals due to its resolution 226Ac both as an element-equivalent isotope for 225Ac radiopharmaceuticals, or as a standalone therapeutic isotope.

Two AC magnets were installed to scan the 500 MeV proton beam in a circular pattern on the TRIUMF ISAC target. Rotating the proton beam produces a more uniform average power deposition, which increases the maximum amount of total beam power that targets can tolerate. The magnet system consists of a pair of two ferrite AC magnets that rotate the proton beam at a frequency of up to 400 Hz. A new tune was developed to produce a controllable spot size, while having an approximate parallel beam on target and a 90° phase advance between the raster magnets and the target. A set of diagnostics was developed to monitor the rotating beam. Online tests have shown that we can increase the radioactive ion beams (RIB) yields from a target while maintaining same maximum temperature.

To improve the thermal modelling of high power isotope separation on-line (ISOL) targets at TRIUMF, an optical technique is being developed that allows for direct off-line and on-line temperature measurements of targets for radioactive isotope production. In this setup the light coming from a hot target through the ionizer opening is collected via a set of optics and coupled into a spectrometer. Thus, from the emission spectrum and Planck’s law, the target temperature can be deduced. Tantalum targets were heated to high temperatures and preliminary temperature measurements confirm the correlation between the spectrum of the radiation emitted from the target and the currents used to resistively heat the targets. The final goal is to apply this technique to on-line targets and correlate the isotope releases with the target temperatures for a better understanding of the diffusion and effusion processes happening in the target and for optimizing the delivery of short-lived species.

With the product TopPlusOpen, the Federal Agency for Cartography and Geodesy (BKG) has for the first time provided a freely accessible web map, which is based entirely on open or free data ...

Limited types of radioactive molecules (RM) can be made inside hot-cavity targets at ISOL facilities like TRIUMF. However, extreme conditions in these targets present formidable unsolved challenges to efficient production and delivery of RM’s. Here we propose using RFQ gas-reaction cells to produce RM from radioactive ion beams (RIB) by room temperature RIB-gas chemical reactions at eV energies. Two options are possible: (1) using an ion reaction cell (IRC) that is a linear RFQ ion guide and reaction cell used as an ‘on-line ion source’, and (2) using the ARIEL RFQ cooler-buncher (ARQB). RFQ gas-cells are a controllable and efficient method to produce RM from chemical reactants that cannot be used in ISOL targets. This ‘online chemistry’ offers a way to enable groundbreaking Beyond Standard Model (BSM) physics research, using a wide diversity of new rare and exotic RM beams that would be difficult or impossible to produce in hot-cavity targets.

Thorium targets were irradiated with 438-MeV protons, resulting in spallation and high-energy fission reactions. The measured production cross sections of 38 nuclides in the mass range 83 to 233 are reported. These cross-section data are useful for validating nuclear interaction models and are compared to simulated cross sections calculated using three different Monte Carlo packages, fluka (version 2011.2x.7), geant4 (version 10.6, with the Liege intranuclear cascade model and the abla version 3.1 evaporation code), and geant4 (version 10.6, with the binary cascade model). These data are also useful for estimating radionuclide production yields following an irradiation, in particular for the production of $^{225}\mathrm{Ac}$, a radionuclide of currently heightened interest in nuclear medicine for the treatment of cancer. For most nuclides reported, the measured, literature, and simulated cross-section values agree within a factor of 2.

Production of medical radionuclides with ISOL facilities is a unique production method that may provide access to preclinical quantities of some rare and potent radionuclides for nuclear medicine. Particularly attention over the past years was focused on several promising candidates for Targeted Radionuclides Therapy (TRT). With this review, we provide some perspectives of using the TRIUMF ISOL facility (ISAC) to produce medical radionuclides for TRT application and highlight our current effort to collect of

Hot cavity resonant ionization laser ion sources (RILIS) provide a multitude of radioactive ion beams with high ionization efficiency and element selective ionization. However, in hot cavity RILIS there still remains isobaric contamination in the extracted beam from surface ionized species. An ion guide-laser ion source (IG-LIS) has been implemented at TRIUMF’s isotope separator and accelerator (ISAC) facility that decouples the hot isotope production region from the laser ionization volume. A number of IG-LIS runs have been conducted to provide isobar free radioactive ion beams for experiments. Isobar suppression of up to 106 has been achieved, e.g. for Mg, Cd, Ga and other isotopes, IG-LIS however, still suffers from an intensity loss of 50-100× as compared to hot cavity RILIS. The work towards operating the IG-LIS in an optimized fashion and possible design improvements to the operational prototype for efficient and robust (radiation hard) on-line operation and recent SIMION ion optics simulation results as well as the ongoing development status of the IG-LIS are presented.

A computer simulation of the radioactive isotope beam targets used at the Isotope Separation and ACceleration (ISAC) facility of TRIUMF was built, to support target material development. The simulation was constructed using the GEANT4 nuclear transport toolkit, and can simulate the production rate of isotopes from user-defined beam and target characteristics. This GEANT4 simulation produces isotopes using the Liege intra-nuclear cascade, coupled to the ABLAv3 de-excitation code and consists of a primary 480 MeV proton beam impinging upon a production target. The isotopes produced by this interaction are used to calculate in-target production rates. Results from the simulation are presented, alongside an analysis of the release times of a subset of the francium isotopes, 211–214 Fr.

Effective use of the decay chain in targeted internal radioimmunotherapy requires the retention of both and progeny isotopes at the target site. Imaging-based pharmacokinetic tests of these pharmaceuticals must therefore separately yet simultaneously image multiple isotopes that may not be colocalized despite being part of the same decay chain. This work presents feasibility studies demonstrating the ability of a microSPECT/CT scanner equipped with a high energy collimator to simultaneously image two components of the decay chain: (218 keV) and (440 keV). Image quality phantoms were used to assess the performance of two collimators for simultaneous and imaging in terms of contrast and noise. A hotrod resolution phantom containing clusters of thin rods with diameters ranging between 0.85 and 1.70 mm was used to assess resolution. To demonstrate ability to simultaneously image dynamic and activity distributions, a phantom containing a generator from was imaged. These tests were performed with two collimators, a high-energy ultra-high resolution (HEUHR) collimator and an ultra-high sensitivity (UHS) collimator. Values consistent with activity concentrations determined independently via gamma spectroscopy were observed in high activity regions of the images. In hotrod phantom images, the HEUHR collimator resolved all rods for both and images. With the UHS collimator, no rods were resolvable in images and only rods ≥1.3 mm were resolved in images. After eluting the generator, images accurately visualized the reestablishment of transient equilibrium of the decay chain. The feasibility of evaluating the pharmacokinetics of the decay chain in vivo has been demonstrated. This presented method requires the use of a high-performance high-energy collimator.

Introduction The availability of 211 At for targeted alpha therapy research can be increased by the 211 Rn/ 211 At generator system, whereby 211 At is produced by 211 Rn electron capture decay. This study demonstrated the feasibility of using generator-produced 211 At to label monoclonal antibody (BC8, anti-human CD45) for preclinical use, following isolation from the 207 Po contamination also produced by these generators (by 211 Rn α-decay). Methods 211 Rn was produced by 211 Fr electron capture decay following mass separated ion beam implantation and chemically isolated in liquid alkane hydrocarbon (dodecane). 211 At produced by the resulting 211 Rn source was extracted in strong base (2N NaOH) and purified by granular Te columns. BC8-B10 (antibody conjugated with closo -decaborate(2-)) was labeled with generator-produced 211 At and purified by PD-10 columns. Results Aqueous solutions extracted from the generator were found to contain 211 At and 207 Po, isolated from 211 Rn. High radionuclidic purity was obtained for 211 At eluted from Te columns, from which BC8-B10 monoclonal antibody was successfully labeled. If not removed, 207 Po was found to significantly contaminate the final 211 At-BC8-B10 product. High yield efficiencies (decay-corrected, n =3) were achieved for 211 At extraction from the generator (86%±7%), Te column purification (70%±10%), and antibody labeling (76%±2%). Conclusions The experimental 211 Rn/ 211 At generator was shown to be well-suited for preclinical 211 At-based research. Advances in knowledge We believe that these experiments have furthered the knowledge-base for expanding accessibility to 211 At using the 211 Rn/ 211 At generator system. Implications for patient care As established by this work, the 211 Rn/ 211 At generator has the capability of facilitating preclinical evaluations of 211 At-based therapies.

Mass-separated francium beams (211Fr or 213Fr) were implanted into solid targets for producing 211Rn (14.6h half-life) or 209At (5.41h), in situ. 211Rn was transferred to dodecane and isolated from contaminants, providing sources for 211At (7.21h) production by 211Rn decay (73%). 209At was recovered with high radionuclidic purity in aqueous solutions, directly. These experiments demonstrated Fr beam implantations as a novel method for producing preclinical quantities of 211Rn/211At (for therapy) and 209At (for imaging).

TRIUMF has a long history of medical isotope production. For more than 40 years, the Life Sciences Division at TRIUMF has produced isotopes for Positron Emission Tomography (PET) for the local hospitals. Recently, the division has taken on the challenge to expand the facility's isotope repertoire to isotopes for imaging to treatment. At the smallest cyclotron at TRIUMF with energy of 13 MeV, radiometals are being produced in a liquid target which is typically used for PET isotope production. This effort makes radiometals available for early stage research and preclinical trials. At beam energy of 24 MeV, we produce 99mTc from 100Mo with a cyclotron, the most common isotope for Single-Photon-Emission-Computed-Tomography (SPECT) and the most common isotope for nuclear imaging. The use of a cyclotron bypasses the common production route via a nuclear reactor as well as enriched uranium. And finally, at our 500 MeV cyclotron we have demonstrated the production of α emitters useful for targeted alpha therapy. Herein, these efforts are summarized.

We report on high-statistics data from the $\beta^-$ decay of the $^{46}$K $J^{\pi}$ = 2$^-$ ground state taken with the GRIFFIN spectrometer located at the TRIUMF-ISAC facility. In total, 199 $\gamma$ rays and 42 excited states were placed in the level scheme, and from the observed $\beta$ feeding and angular correlations of pairs of cascading $\gamma$ rays, it was possible to assign spins and parities to excited states and determine mixing ratios for selected $\gamma$ rays. The level structure of $^{46}$Ca is compared to theoretical predictions from a microscopic valence-space Hamiltonian derived from two- (NN) and three-nucleon (3N) forces. These calculations are in reasonable agreement with the experimental data and indicate that the protons in this region are not as inert as would be expected for semi-magic nuclei.

In-source resonance ionization spectroscopy of the neutron-rich actinium isotopes $^{225\ensuremath{-}229}\mathrm{Ac}$ has been performed at the ISAC facility in TRIUMF, probing a $^{2}D_{3/2}\ensuremath{\rightarrow}^{4}P_{5/2}^{\ensuremath{\circ}}$ atomic transition. New data on the magnetic dipole moments and changes in mean-square charge radii $\ensuremath{\delta}\ensuremath{\langle}{r}^{2}\ensuremath{\rangle}$ of $^{226,228,229}\mathrm{Ac}$ have been obtained. The comparison of the measured isotope shifts and magnetic dipole coupling constants $a(^{4}P_{5/2}^{\ensuremath{\circ}})$ of $^{225,227}\mathrm{Ac}$ with a high-resolution data set is used to identify systematic uncertainties on the deduced $\ensuremath{\delta}{\ensuremath{\langle}{r}^{2}\ensuremath{\rangle}}^{A,215}$ and magnetic dipole moment values. The charge radii odd-even staggering is evaluated for the odd-$N$ isotopes, showing that $^{226}\mathrm{Ac}$ has an inverted odd-even staggering that might be linked with a reflection-asymmetric shape. Comparison of the magnetic dipole moments of $^{225,227,229}\mathrm{Ac}$ with Nilsson-model estimates supports the assumption of octupole deformation in isotopes $^{225,227}\mathrm{Ac}$ and its gradual decrease toward isotope $^{229}\mathrm{Ac}$. The changes in mean-square charge radii are compared to self-consistent calculations employing multiple modern energy density functionals: SLy5s1, BSk31, and DD-MEB1. For SLy5s1 in particular, self-consistent time-reversal breaking calculations of odd-odd nuclei incorporating finite octupole deformation are reported for the first time. For these calculations, the overall best agreement is obtained when the octupole degree of freedom is taken into account.

Background Actinium-225 (225Ac, t1/2 = 9.9 d) is a promising candidate radionuclide for use in targeted alpha therapy (TAT), though the currently limited global supply has hindered the development of a suitable Ac-chelating ligand and 225Ac-radiopharmaceuticals towards the clinic. We at TRIUMF have leveraged our Isotope Separation On-Line (ISOL) facility to produce 225Ac and use the resulting radioactivity to screen a number of potential 225Ac-radiopharmaceutical compounds. Results MBq quantities of 225Ac and parent radium-225 (225Ra, t1/2 = 14.8 d) were produced and separated using solid phase extraction DGA resin, resulting in a radiochemically pure 225Ac product in > 98% yield and in an amenable form for radiolabeling of ligands and bioconjugates. Of the many polydentate picolinic acid (“pa”) containing ligands evaluated (H4octapa [N4O4], H4CHXoctapa [N4O4], p-NO2-Bn-H4neunpa [N5O4], and H6phospa [N4O4]), all out-performed the current gold standard, DOTA for 225Ac radiolabeling ability at ambient temperature. Moreover, a melanocortin 1 receptor-targeting peptide conjugate, DOTA-modified cyclized α-melanocyte-stimulating hormone (DOTA-CycMSH), was radiolabeled with 225Ac and proof-of-principle biodistribution studies using B16F10 tumour-bearing mice were conducted. At 2 h post-injection, tumour-to-blood ratios of 20.4 ± 3.4 and 4.8 ± 2.4 were obtained for the non-blocking (molar activity [M.A.] > 200 kBq/nmol) and blocking (M.A. = 1.6 kBq/nmol) experiment, respectively. Conclusion TRIUMF’s ISOL facility is able to provide 225Ac suitable for preclinical screening of radiopharmaceutical compounds; [225Ac(octapa)]−, [225Ac(CHXoctapa)]−, and [225Ac(DOTA-CycMSH)] may be good candidates for further targeted alpha therapy studies. Electronic supplementary material The online version of this article (10.1186/s41181-019-0072-5) contains supplementary material, which is available to authorized users.

The experimental determination of atomic levels and the first ionization potential of the heaviest elements ( Z ⩾ 100 ) is key to challenge theoretical predictions and to reveal changes in the atomic shell structure. These elements are only artificially produced in complete-fusion evaporation reactions at on-line facilities such as the GSI in Darmstadt at a rate of, at most, a few atoms per second. Hence, highly sensitive spectroscopic methods are required. Laser spectroscopy is one of the most powerful and valuable tools to investigate atomic properties. In combination with a buffer-gas filled stopping cell, the Radiation Detected Resonance Ionization Spectroscopy (RADRIS) technique provides the highest sensitivity for laser spectroscopy on the heaviest elements. The RADRIS setup, as well as the measurement procedure, have been optimized and characterized using the α -emitter 155 Yb in on-line conditions, resulting in an overall efficiency well above 1%. This paves the way for a successful search of excited atomic levels in nobelium and heavier elements.

Resonance ionization spectroscopy of nobelium (atomic number 102) reveals its ground-state transition and an upper limit for its ionization potential, paving the way to characterizing even heavier elements via optical spectroscopy. Characterizing the heaviest elements in the periodic table is a gruelling task because they are radioactive, exist only for split seconds at a time and need to be artificially produced in sufficient quantities by complicated procedures. The heaviest element that has been characterized by optical spectroscopy is fermium, which has an atomic number of 100. Mustapha Laatiaoui et al. extend the methods used for fermium to perform optical spectroscopy on nobelium (atomic number 102). Through laser resonance ionization spectroscopy, they identify the ground-state transition of the atom and manage to investigate highly excited states called Rydberg states. This allows them to determine an upper limit for the atomic ionization potential of nobelium. This study opens the door to the characterization of even heavier elements such as lawrencium using optical spectroscopy. Optical spectroscopy of a primordial isotope has traditionally formed the basis for understanding the atomic structure of an element. Such studies have been conducted for most elements1 and theoretical modelling can be performed to high precision2,3, taking into account relativistic effects that scale approximately as the square of the atomic number. However, for the transfermium elements (those with atomic numbers greater than 100), the atomic structure is experimentally unknown. These radioactive elements are produced in nuclear fusion reactions at rates of only a few atoms per second at most and must be studied immediately following their production4, which has so far precluded their optical spectroscopy. Here we report laser resonance ionization spectroscopy of nobelium (No; atomic number 102) in single-atom-at-a-time quantities, in which we identify the ground-state transition 1S0 1P1. By combining this result with data from an observed Rydberg series, we obtain an upper limit for the ionization potential of nobelium. These accurate results from direct laser excitations of outer-shell electrons cannot be achieved using state-of-the-art relativistic many-body calculations5,6,7,8 that include quantum electrodynamic effects, owing to large uncertainties in the modelled transition energies of the complex systems under consideration. Our work opens the door to high-precision measurements of various atomic and nuclear properties of elements heavier than nobelium, and motivates future theoretical work.

High intensity 11C beams are necessary for the investigation of the formation of 12C via the nuclear reaction 11C(p, γ)12N → 12C + e+ + ν. The production of intense carbon beams on-line is quite challenging due to the thermodynamic properties and chemical reactivity of carbon at high temperatures. A previous attempt, using a medical isotope cyclotron production method in batch mode, was not conclusive. The intensity obtained was at least one order of magnitude too low for a direct proton capture experiment using the DRAGON facility at ISAC/TRIUMF. Producing a 11C beams using the ISOL method requires a target capable of efficiently releasing the carbon isotopes. NiO has been selected as a target material because most of the nickel carbides are not stable at high temperature. The development of carbon beams using a composite NiO/Ni target on-line is described.

The ISAC facility (Isotope Separation and Acceleration) at TRIUMF has recently started to provide isotopes for pre-clinical nuclear medicine studies. By irradiating ISOL (Isotope Separation OnLine) targets with a 480 MeV proton beam from the TRIUMF H- cyclotron, the facility can deliver a large variety of radioactive isotope beams (RIB) for research in the fields of nuclear astrophysics, nuclear structure and material science with half-lives down to a few milliseconds via an electrostatic beamline network. For the collection of medical isotopes, typically with half-lives in the range of hours or days, we have developed a compact apparatus for the implantation of mass-separated RIB on a target disc at energies between 20-55 keV. In this paper, we also discuss two different retrieval methods of the implanted activity from the implantation target: by chemical etching of the target surface and by recoil collection of implanted alpha emitters.

Until recently, ground-state nuclear moments of the heaviest nuclei could only be inferred from nuclear spectroscopy, where model assumptions are required. Laser spectroscopy in combination with modern atomic structure calculations is now able to probe these moments directly, in a comprehensive and nuclear-model-independent way. Here we report on unique access to the differential mean-square charge radii of ^{252,253,254}No, and therefore to changes in nuclear size and shape. State-of-the-art nuclear density functional calculations describe well the changes in nuclear charge radii in the region of the heavy actinides, indicating an appreciable central depression in the deformed proton density distribution in ^{252,254}No isotopes. Finally, the hyperfine splitting of ^{253}No was evaluated, enabling a complementary measure of its (quadrupole) deformation, as well as an insight into the neutron single-particle wave function via the nuclear spin and magnetic moment. numpages: 6 ispartof: PHYSICAL REVIEW LETTERS vol:120 issue:23 pages:232503-232503 ispartof: location:United States status: Published online

One of the most important atomic properties governing an element's chemical behavior is the energy required to remove its least-bound electron, referred to as the first ionization potential. For the heaviest elements, this fundamental quantity is strongly influenced by relativistic effects which lead to unique chemical properties. Laser spectroscopy on an atom-at-a-time scale was developed and applied to probe the optical spectrum of neutral nobelium near the ionization threshold. The first ionization potential of nobelium is determined here with a very high precision from the convergence of measured Rydberg series to be 6.626 21±0.000 05 eV. This work provides a stringent benchmark for state-of-the-art many-body atomic modeling that considers relativistic and quantum electrodynamic effects and paves the way for high-precision measurements of atomic properties of elements only available from heavy-ion accelerator facilities. ispartof: PHYSICAL REVIEW LETTERS vol:120 issue:26 pages:263003-263003 ispartof: location:United States status: published

Effective use of the [Formula: see text] decay chain in targeted internal radioimmunotherapy requires the retention of both [Formula: see text] and progeny isotopes at the target site. Imaging-based pharmacokinetic tests of these pharmaceuticals must therefore separately yet simultaneously image multiple isotopes that may not be colocalized despite being part of the same decay chain. This work presents feasibility studies demonstrating the ability of a microSPECT/CT scanner equipped with a high energy collimator to simultaneously image two components of the [Formula: see text] decay chain: [Formula: see text] (218 keV) and [Formula: see text] (440 keV). Image quality phantoms were used to assess the performance of two collimators for simultaneous [Formula: see text] and [Formula: see text] imaging in terms of contrast and noise. A hotrod resolution phantom containing clusters of thin rods with diameters ranging between 0.85 and 1.70 mm was used to assess resolution. To demonstrate ability to simultaneously image dynamic [Formula: see text] and [Formula: see text] activity distributions, a phantom containing a [Formula: see text] generator from [Formula: see text] was imaged. These tests were performed with two collimators, a high-energy ultra-high resolution (HEUHR) collimator and an ultra-high sensitivity (UHS) collimator. Values consistent with activity concentrations determined independently via gamma spectroscopy were observed in high activity regions of the images. In hotrod phantom images, the HEUHR collimator resolved all rods for both [Formula: see text] and [Formula: see text] images. With the UHS collimator, no rods were resolvable in [Formula: see text] images and only rods ⩾1.3 mm were resolved in [Formula: see text] images. After eluting the [Formula: see text] generator, images accurately visualized the reestablishment of transient equilibrium of the [Formula: see text] decay chain. The feasibility of evaluating the pharmacokinetics of the [Formula: see text] decay chain in vivo has been demonstrated. This presented method requires the use of a high-performance high-energy collimator.

Developments at TRIUMF’s isotope separator and accelerator (ISAC) resonance ionization laser ion source (RILIS) in the past years have concentrated on increased reliability for on-line beam delivery of radioactive isotopes to experiments, as well as increasing the number of elements available through resonance ionization and searching for ionization schemes with improved efficiency. The current status of these developments is given with a list of two step laser ionization schemes implemented recently.

International audience; Using the sensitive Radiation Detected Resonance Ionization Spectroscopy (RADRIS) techniquean optical transition in neutral nobelium (No, Z = 102) was identified. A remnant signal when delaying the ionizing laser indicated the influence of a strong buffer gas induced de-excitation of the optically populated level. A subsequent investigation of the chemical homologue, ytterbium (Yb, Z = 70), enabled a detailed study of the atomic levels involved in this process, leading to the development of a rate equation model. This paves the way for characterizing resonance ionization spectroscopy (RIS) schemes used in the studyof nobelium and beyond, where atomic properties are currently unknown.

Resonance Ionization Laser Ion Sources (RILIS) are efficient and element selective ion sources, which are well suited for radioactive ion beam facilities. Using TRIUMF's off-line laser ion source test stand with a system of tunable titanium sapphire (Ti:Sa) lasers, laser resonance ionization schemes for lutetium (Lu) and praseodymium (Pr) have been investigated with a particular focus on autoionizing states. New ionization schemes via Rydberg states and autoionizing states were found and compared at the off-line test stand. The data from on-line RILIS delivery of Lu radioactive isotopes is presented.

The present status of the ISAC facility for rare isotopes beams after its first 10 years of operation is presented. Planning for the ISAC facility started in 1985 with the Parksville workshop on radioactive ion beams (Buchmann and D’Auria 1985). It was put on halt by the KAON proposal and planning was only resumed in 1993 after the cancellation of KAON. The ISAC facility was built to satisfy the scientific need for accelerated beams of rare isotopes for use in applications such as nuclear physics, nuclear astrophysics, atomic and condensed matter physics as well as medicine. At the time of the ISAC proposal submission, a number of facilities were either planned or under construction. In order to have an impact in the field, the requirements and specifications for the driver beam intensity on target was set to 100 µA, 500 MeV protons, which for ISAC results in a driver beam power of 50 kW.

The production of radioactive ion beams (RIB) from spallation targets by irradiation with a continuous 500 MeV proton beam, has been routine at TRIUMF for several years. Based on the experience with composite refractory carbide targets a procedure for the fabrication of UC 2 /C targets was developed. It includes the preparation of UC 2 by carbothermal reduction of UO 2 , the slip-casting of fine-grained UC 2 /C slurry on graphite foil under inert gas atmosphere and the cutting of composite target discs which are stacked up to a lamellar structure. The thermal properties of such an arrangement are adequate to withstand the high power deposition of an intense, continuous proton beam and also beneficial for the fast release of short-lived radioactive isotopes. Molecular structure, particle size and the impact of sintering of the target discs were investigated via XRD and SEM. Thickness and mass distribution were measured with position-sensitive L III -edge densitometry. The results confirm that the properties of the UC 2 /C target material are well suited for RIB production at TRIUMF while there is still room for improvement with regard to uniformity of mass distribution in target disc thickness.

The availability ofAqueous solutions extracted from the generator were found to containThe experimentalWe believe that these experiments have furthered the knowledge-base for expanding accessibility toAs established by this work, the

The development of alpha-emitting radiopharmaceuticals using 211At requires quantitative determination of the time-dependent nature of the 211At biodistribution. However, imaging-based methods for acquiring this information with 211At have not found wide-spread use because of its low abundance of decay emissions suitable for external detection. In this publication we demonstrate the theranostic abilities of the 211At/209At isotope pair and present the first-ever 209At SPECT images. The VECTor microSPECT/PET/CT scanner was used to image 209At with a collimator suitable for the 511 keV annihilation photons of PET isotopes. Data from distinct photopeaks of the 209At energy spectrum (195 keV (22.6%), 239 keV (12.4 %), 545 keV (91.0 %), a combined 782/790 keV peak (147 %), and 209Po x-rays (139.0 %)) were independently evaluated for use in image reconstructions using Monte Carlo (GATE) simulations and phantom studies. 209At-imaging in vivo was demonstrated in a healthy mouse injected with 10 MBq of free [209At]astatide. Image-based measurements of 209At uptake in organs of interest—acquired in 5 min intervals—were compared to ex vivo gamma counter measurements of the same organs. Simulated and measured data indicated that—due to the large amount of scatter from high energy (>750 keV) gammas—reconstructed images using the x-ray peak outperformed those obtained from other peaks in terms of image uniformity and spatial resolution, determined to be

The $ \beta^{{+}}_{}$ /EC decay of 189m, gPb has been studied at the ISOLDE facility using nuclear spectroscopy and in-source laser spectroscopy. A level scheme of 189Tl has been built from $ \gamma$ - $ \gamma$ coincidence relationships and information on the feeding of some excited levels of 189Tl provided by the hyperfine spectra obtained from laser ionization. The half-lives of both the 13/2+ and 3/2- 189Pb isomers have been estimated to be T 1/2 = 50±3 s and T 1/2 = 39±8 s, respectively. Calculations have been performed for different oblate and prolate nuclear deformations using an axial-rotor coupled to one-quasiparticle model, a structure has been suggested for the low-lying levels of the 189Tl nucleus.

Planar channeling has been studied for silicon single crystals at a beam energy of 855 MeV at the Mainz Microtron MAMI. Complex channeling patterns were observed from which the crystal orientation can unambiguously be determined. Photon spectra at (1 0 0), (1 1 0) and (1 1 1) planar channeling were recorded with a 10″ × 10″ NaI detector. The planar (1 1 0) channeling process has been studied as function of the crystal thickness in the range between 7.9 and 270 μm from which a dechanneling length of 18.0 μm and the thickness dependent rechanneling lengths were deduced, employing solutions of the Fokker–Planck equation. A signal derived from high energy bremsstrahlung exhibits a characteristic length of (32 ± 4) μm which is tentatively interpreted as the occupation length of the lowest quantum states in the planar potential. Prospects are discussed to exploit channeling of high energy electrons in periodically bent silicon single crystals for production of radiation in the hundreds keV to multi MeV range.

Purpose To compare three different autocalibrated parallel acquisition techniques (PAT) for quantitative and semiquantitative myocardial perfusion imaging. Materials and Methods Seven healthy volunteers underwent myocardial first-pass perfusion imaging at rest using an SR-TrueFISP pulse sequence without PAT and while using GRAPPA, mSENSE, and TSENSE. signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), normalized upslopes (NUS), and myocardial blood flow (MBF) were calculated. Artifacts, image noise, and overall image quality were qualitatively assessed. Furthermore, the relation between signal intensity (SI) and contrast medium (CM) concentration was determined in phantoms. Results Using PAT the linear range of the SR-TrueFISP sequence was increased about 40%. All three PAT methods introduced significant loss in SNR and CNR. GRAPPA yielded slightly better values then mSENSE and TSENSE. Both SENSE techniques introduced significantly residual aliasing artifacts. Image noise was increased with all three PAT methods. However, overall image quality was reduced only with mSENSE. Even though GRAPPA yielded smaller NUS values than non-PAT, mSENSE, and TSENSE, no differences were found in MBF between all applied techniques. Conclusion Quantitative and semiquantitative myocardial perfusion imaging can benefit from PAT due to shorter acquisition times and increased linearity of the pulse sequence. GRAPPA and TSENSE turned out to be well suited for quantitative myocardial perfusion imaging. J. Magn. Reson. Imaging 2008;28:51–59. © 2008 Wiley-Liss, Inc.